Sep 17, 2026 · 25 min
Testosterone debates expose the stakes of muscle preservation
The Truth About Testosterone in Women
The episode separates supervised hormone therapy from steroid misuse while connecting protein, resistance training, and rapid weight loss to women’s long-term health.
- 1Medically supervised testosterone therapy differs fundamentally from supraphysiologic anabolic-androgenic steroid use.
- 2Testosterone may affect women’s muscle, bone, sexuality, and body composition, but risks include liver toxicity and permanent voice changes.
- 3Rapid weight loss with inadequate protein and resistance training can accelerate lean-mass loss and raise sarcopenia concerns, including alongside GLP-1 medications.
Don't miss
Lyon reframes the steroid conversation as a muscle-preservation problem, linking rapid weight loss and inadequate training to potential frailty.
The brief
Dr. Gabrielle Lyon opens by challenging loose steroid language and warning that rapid weight loss, inadequate protein, and insufficient resistance training can worsen lean-mass loss.
The episode distinguishes medically supervised testosterone therapy from supraphysiologic anabolic-androgenic steroid use, a difference that changes both the potential benefits and the risks.
Testosterone is discussed in relation to women’s muscle, bone, sexuality, and body composition, alongside hazards including liver toxicity, counterfeit products, and permanent voice changes.
GLP-1 medications become part of a broader muscle-preservation problem: the concern is not the drugs alone, but how weight loss is managed.
The central takeaway is that protecting against frailty requires a fuller body-composition conversation, not imprecise warnings about steroids or weight-loss medications.